Patents Assigned to Research Development
  • Publication number: 20140046408
    Abstract: A method of stimulating neurons present in a living body is disclosed. The method comprises directing light to an artificial light absorbing medium implanted extracellularly at a target location having the neurons therein, wherein wavelengths and intensities of the light are selected so as to heat the light absorbing medium by light absorption. The heating is sufficient to stimulate neurons nearby the light absorbing medium. In some embodiments, the light is spatially modulating so as to encode a stimulation pattern therein.
    Type: Application
    Filed: October 20, 2013
    Publication date: February 13, 2014
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Shy SHOHAM, Nairouz Farah, Lior Golan
  • Publication number: 20140043064
    Abstract: There is provided a circuit and method for detecting a bad clock condition on a clock signal that includes sampling the value of the clock signal at a first plurality of time delays following a rising edge on the clock signal. This method also includes sampling the value of the clock signal at a second plurality of time delays following a falling edge on the clock signal.
    Type: Application
    Filed: October 22, 2013
    Publication date: February 13, 2014
    Applicant: STMicroelectronics (Research & Development) Limited
    Inventor: Mark Trimmer
  • Patent number: 8646443
    Abstract: An electrochemically reacting composition which can be utilized as a source of heat as well as hydrogen, comprising the active materials aluminum, magnesium and iron, a filler material such as a silica sand, a hydrogen scavenger such as potassium permanganate, additives such as sodium silicate and an electrolyte such as sodium chloride.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: February 11, 2014
    Assignee: The Additional Director (IPR), Defence Research & Development Organisation
    Inventors: Pramil C. Deb, Arun Kumar Shah, Daya Lama
  • Publication number: 20140037659
    Abstract: The present invention relates to diagnostic and prognostic methods and kits for assessing chronic inflammation and associated immune-suppression. More particularly, the invention relates to the use of SNX9 (sorting nexin 9 protein) as a biomarker for chronic inflammation and associated immune-suppression, specifically, in subjects suffering from chronic inflammatory conditions. The invention further provides a prognostic tool for detecting regression or recurrence of the diseases and a powerful tool for assessing efficacy of a treatment. The present invention further provides SNX9 as an immunomodulator and therefore relates to methods for treating immune-related disorders by modulating SNX9 expression.
    Type: Application
    Filed: January 31, 2012
    Publication date: February 6, 2014
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Michal Baniyash, Eliran Ish Shalom
  • Patent number: 8644591
    Abstract: An alignment method for assembling substrates without fiducial mark is provided and has steps of: pre-defining at least two partially standard character regions; capturing at least two partially actual images of a first substrate; comparing to obtain at least two partially actual character regions; building an actual coordinate system of the first substrate; comparing the actual coordinate system with a coordinate system of a second substrate to obtain three types of offset values; moving the first substrate to a correct waiting position based on the offset values; ensuring if the first substrate is disposed at the correct waiting position; and stacking the first substrate with the second substrate to finish the alignment and installation. Thus, the alignment method of the present invention can be applied to to-be-installed substrates without any fiducial mark for alignment.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: February 4, 2014
    Assignee: Metal Industries Research & Development Centre
    Inventors: Chorng-tyan Lin, Chih-chin Wen, Chun-ming Yang, Jwu-jiun Yang
  • Patent number: 8642058
    Abstract: The present application is directed to a novel composition which acts as a barrier to noxious agents while adding self-detoxifying catalytic treatments to neutralize the noxious and harmful warfare agents when applied for example on a fabric, or other solid support.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: February 4, 2014
    Assignees: U.S. Army Natick Soldier Research, Development and Engineering Center Chemical Technology Team, Stedfast Inc.
    Inventors: Hamid Benaddi, Heidi Schreuder-Gibson
  • Patent number: 8642288
    Abstract: Provided is a method of focusing particles. The method includes: providing a suspension of the particles in a suspending medium; and flowing the suspension along a channel, such that the flowing suspension occupies a certain volume that has at least one cross-sectional dimension smaller than 100 ?m. The suspending medium has such viscoelastic properties, that flowing the suspension in the channel directs at least some of the particles towards a focus region, enclosed in said certain volume.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: February 4, 2014
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Alexander Leshansky, Avishay Bransky, Korin Natanel
  • Publication number: 20140027606
    Abstract: A module operates in a proximity detection mode and a gesture detection mode. The module includes an illumination source, radiation sensors and a controller. When in proximity detection mode, the illumination source emits radiation, the radiation sensors measure the radiation level, and the controller adjusts the measured radiation level to substantially cancel the contribution attributable to ambient radiation to determine the presence of a proximate object by. When in the gesture recognition mode, the level of radiation incident on the sensors is individually sampled, and the controller determines object movement by comparing the changes in the measured radiation levels over a plurality of the samples. Ambient radiation contribution is not removed from the sampled radiation levels during the gesture recognition mode.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 30, 2014
    Applicant: STMicroelectronics (Research & Development) Limited
    Inventors: Jeffrey M. Raynor, Andrew Scott
  • Publication number: 20140031526
    Abstract: The present invention relates to methods for generation of high molecular ordered fibrilar structures. More particularly, the method of the invention utilizes CBD's (cellulose binding domain) ability to form dimers for directing ordered assembly of fibrous proteins such as silk proteins into super-molecular fibrilar structures. The invention further provides fibrilar structures such as fibers and articles comprising said fibrilar structures.
    Type: Application
    Filed: February 2, 2012
    Publication date: January 30, 2014
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Oded Shoseyov, Shaul Lapidot, Sigal Meirovitch
  • Publication number: 20140033370
    Abstract: The invention relates to a method to screen for a nucleic acid molecule encoding a polypeptide involved in the synthesis of naringenin chalcone which demonstrates altered expression, activity or substrate specificity. The invention further relates to nucleic acid molecules identified by said screen and to transgenic plants modified to express said nucleic acid molecule.
    Type: Application
    Filed: December 8, 2011
    Publication date: January 30, 2014
    Applicant: Yissuem Research Development Company of the Hebrew University of Jerusalem LTD.
    Inventors: Hagai Abeliovich, Moti Alberstein
  • Publication number: 20140024677
    Abstract: Methods and compositions for inducing mitochondrial biogenesis are provided. In some aspects, methods for the treatment of diseases such as acute kidney disease (AKI) or a muscle wasting disease by administering tomoxetine, nisoxetine, fenoterol, formoterol, or procaterol to an individual are provided.
    Type: Application
    Filed: April 9, 2013
    Publication date: January 23, 2014
    Applicant: MUSC Foundation For Research Development
    Inventors: Rick G. SCHNELLMANN, Craig C. BEESON, Yuri K. PETERSON
  • Patent number: 8633028
    Abstract: Methods for inducing systemic, non-specific and/or sequence specific immune responses in invertebrates, e.g., marine invertebrates such as mollusks, porifera, ctenophora, echinodermas, marine worms, cnideria and preferably crustaceans, by the administration of at least one dsRNA, that confers immunity against a pathogen, or modulates expression of gene that affects growth, reproduction, and general health or “robustness” are provided. Also provided are methods of identifying invertebrate genes, e.g., crustacean genes, the expression of which is involved in the induction of non-specific (systemic) immune responses against pathogens. Also disclosed are preferred delivery systems and methods for stably administering at least one dsRNA to a crustacean whereby the dsRNA is administered via injection, immersion, in a feed or nutrient medium or comprised in a microorganism, e.g., yeast or microalgae, that expresses said dsRNA and is ingestible by said crustacean, e.g., a shrimp.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: January 21, 2014
    Assignee: MUSC Foundation for Research Development
    Inventors: Paul S. Gross, Gregory Warr, Robert Chapman, Craig Browdy, Javier Robalino
  • Patent number: 8633196
    Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: January 21, 2014
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Sandrine Chambon, Laurent Chantalat, Carine Rosignoli, Olivier Roye, Jean-Claude Pascal, Marlène Schuppli-Nollet
  • Patent number: 8633852
    Abstract: A first position of a satellite is calculated at a first time in dependence on received orbit data corresponding to an orbit path of the satellite. Anan orbit path of the satellite is modeled from the first position at the first time to a second time to determine a second position of the satellite at the second time. A third position of the satellite is then calculated at the second time in dependence on the received orbit data. The second position and third position are compared to determine a validity of the orbit data.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: January 21, 2014
    Assignee: STMicroelectronics (Research & Development) Limited
    Inventor: Peter Bagnall
  • Patent number: 8633250
    Abstract: Disclosed herein are compositions and methods for promoting the repair and regeneration of injured tissues, such as injuries resulting from ischemic damage.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: January 21, 2014
    Assignee: MUSC Foundation for Research Development
    Inventors: Rick G. Schnellmann, Shougang Zhuang
  • Patent number: 8634301
    Abstract: An algorithm is presented, which may be used to generate LSPs for path-oriented virtual circuit networks. The algorithm maximizes throughput of traffic-flow through the network according to certain constraints which may selected to suit various scenarios and recovery schemes. The algorithm may be used by network operators to maximize financial profit from existing networks which has a predetermined bandwidth capacity.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: January 21, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Reuven Cohen, Gabi Nakibly
  • Publication number: 20140017764
    Abstract: Provided are methods for protein engineering, such as engineering proteases or kinases. The methods may utilize yeast display and/or ER sequestration of proteins or substrates. In some aspects, TEV proteases with altered substrate specificity, potency, and/or efficiency are provided.
    Type: Application
    Filed: June 25, 2013
    Publication date: January 16, 2014
    Applicant: Research Development Foundation
    Inventors: Brent L. IVERSON, George GEORGIOU, Joseph M. TAFT, Li YI
  • Patent number: 8629245
    Abstract: Methods and composition for the screening and isolation of aglycosylated antibody Fc domain polypeptides. For example, in certain aspects methods for identifying aglycosylated Fc domains that bind to Fc receptors or preferentially bind to particular Fc receptors are described. Furthermore, the invention provides aglycosylated Fc domains that bind to Fc receptors with high affinity. Enhanced methods and media for prokaryotic based interaction screening are also provided.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: January 14, 2014
    Assignee: Research Development Foundation
    Inventors: George Georgiou, Sang Taek Jung
  • Patent number: 8629544
    Abstract: A package includes a first die and a second die, at least one of said first and second dies being a memory. The dies are connected to each other through an interface. The interface is configured to transport both control signals and memory transactions. A multiplexer is provided to multiplex the control signals and memory transactions onto the interface such that a plurality of connections of said interface are shared by the control signals and the memory transactions.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: January 14, 2014
    Assignees: STMicroelectronics (Research & Development) Limited, STMicroelectronics S.r.l.
    Inventors: Andrew Michael Jones, Stuart Ryan, Alberto Scandurra
  • Patent number: 8630703
    Abstract: Hydrophobic weak base compounds such as hydrophobic weak base chemotherapeutic agents (which are not an anthracycline) for use in the treatment of medical conditions such as proliferative disease or disorder in a subject, in combination with illumination of a region in a body of the subject which is characterized by the presence of proliferating cells, are disclosed. The hydrophobic weak base compound and a wavelength of illumination are selected such that the hydrophobic weak base compound acts as a therapeutically effective photosensitizer when exposed to the illumination.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: January 14, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yehuda G. Assaraf, Yamit Adar Turgeman, Andrzej M. Skladanowski, Arjan W. Griffioen, Henk Verheul, Kristy Gotink, Hubert Van Den Bergh, Patrycja Nowak-Sliwinska